These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9541176)

  • 1. Cytokine overproduction in healthy first degree relatives of patients with IDDM.
    Hussain MJ; Maher J; Warnock T; Vats A; Peakman M; Vergani D
    Diabetologia; 1998 Mar; 41(3):343-9. PubMed ID: 9541176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased in vitro interleukin-12 production by peripheral blood in high-risk IDDM first degree relatives.
    Szelachowska M; Kretowski A; Kinalska I
    Horm Metab Res; 1997 Apr; 29(4):168-71. PubMed ID: 9178025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects.
    Kretowski A; Myśliwiec J; Szelachowska M; Brzozowski C; Pietruczuk M; Kinalska I
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):45-9. PubMed ID: 11729828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
    Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS
    Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies in children with type I diabetes mellitus and their healthy relatives: in vitro antigen stimulated IgM production, T-cell subsets and islet-cell antibodies.
    Etzioni A; Vardi P; Benderly A; Katz R; Pollack S
    J Clin Lab Immunol; 1987 Dec; 24(4):163-6. PubMed ID: 3329227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin 2 receptor levels in children with type I insulin-dependent diabetes mellitus.
    Gartner LA; Pfeifer MC; Albini C; Francis GL
    Ann Clin Lab Sci; 1995; 25(1):44-51. PubMed ID: 7762968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased secretion of Th2 cytokines precedes Up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus.
    Rapoport MJ; Mor A; Vardi P; Ramot Y; Winker R; Hindi A; Bistritzer T
    J Autoimmun; 1998 Dec; 11(6):635-42. PubMed ID: 9878085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.
    Riley WJ; Maclaren NK; Krischer J; Spillar RP; Silverstein JH; Schatz DA; Schwartz S; Malone J; Shah S; Vadheim C
    N Engl J Med; 1990 Oct; 323(17):1167-72. PubMed ID: 2215594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS; Colman PG; Harrison LC
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.
    Dogan Y; Akarsu S; Ustundag B; Yilmaz E; Gurgoze MK
    Mediators Inflamm; 2006; 2006(1):59206. PubMed ID: 16864906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus.
    Roep BO; Duinkerken G; Schreuder GM; Kolb H; de Vries RR; Martin S
    Eur J Immunol; 1996 Jun; 26(6):1285-9. PubMed ID: 8647206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes.
    Stechova K; Bohmova K; Vrabelova Z; Sepa A; Stadlerova G; Zacharovova K; Faresjö M
    Diabetes Metab Res Rev; 2007 Sep; 23(6):462-71. PubMed ID: 17315139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW
    Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.